SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

A Ninth Circuit ruling that states can regulate or restrict sports-event contracts dealt a setback to Kalshi-style prediction markets, easing a major competitive and regulatory concern for DraftKings and prompting a sharp but contested rebound. Traders remain divided over whether the ruling will materially improve DraftKings long-term margins and market share, given possible further appeals and continued competition from prediction platforms.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

The Federal Reserves interest-rate hike is driving attention, with traders debating whether it was already priced into SOFI and whether higher rates will benefit bank spreads or pressure lending demand, funding costs, and credit. The community is split between buyers who view the move as a priced-in opportunity and skeptics focused on continued macro pressure and the stocks weak performance.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

FDA approval of FAYUVI, the first treatment for Sanfilippo syndrome type A, is driving attention, along with the accompanying Priority Review Voucher and planned commercial launch. Traders are broadly bullish on the approval and potential short covering, though some question the muted share-price reaction, limited patient population, and commercialization and cash-burn risks.

Dutch Bros, Inc. engages in operating and franchising drive-thru shops that focus on handcrafted beverages. It operates through the Company-Operated Shops, and Franchising and Other segments. The Company-Operated Shops segment consists of coffee shop sales to customers. The Franchising and Other segment is involved in bean and product sales to franchisees and includes the initial franchise fees, royalties, and marketing fees. The company was founded by Travis Boersma and Dane Boersma in 1992 and is headquartered in Tempe, AZ.

Dutch Bros Inc - Ordinary Shares - Class A

Dutch Bros Inc

A sharp post-earnings selloff and valuation reset have driven attention, with traders citing the high multiple, consumer and restaurant-sector pressures, and uncertainty around the Salad and Go site deal and possible dilution. Bulls argue that strong growth, store expansion, and continued customer traffic make the decline an opportunity, while bears expect further downside as growth and margins face pressure.

Cerebras Systems, Inc. engages in the designing and provision of processors for artificial intelligence (AI) training and inference. Its products include inference, Wafer Scale Engine, AI supercomputers, AI model services, cloud, systems, and processors. The company was founded by Sean Lie, Andrew D. Feldman, Gary Lauterbach, Michael James, and Jean Philippe Fricker in 2015 and is headquartered in Sunnyvale, CA.

Cerebras Systems Inc - Ordinary Shares - Class A

Cerebras Systems Inc

Cerebras is drawing attention amid repeated staged lockup expirations and insider share sales, which traders say are creating persistent supply and volatility. Bulls continue to point to the companys AI-inference demand, including cloud and data-center partnerships, as a counterpoint to the near-term selling pressure.

Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.

Helus Pharma Inc.

Anticipation is building around Helus Pharmas pivotal Phase 3 HLP003 APPROACH readout, with traders citing ahead-of-schedule enrollment, encouraging Phase 2 results, and recent leadership and insider-buying activity as signs of confidence. The bullish reaction is tempered by debate over whether expectations are already priced in and whether future financing could dilute shareholders.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladocs weaker-than-expected quarterly results and reduced outlook, driven largely by BetterHelps difficult shift from cash-pay to insurance and limited therapist capacity, are dominating attention. Traders are divided between viewing the revenue pressure as a temporary transition bottleneck and seeing it as evidence of poor execution and weak management credibility.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

A new at-the-market equity offering, following the completion of the prior program, has put dilution and insider selling at the center of the discussion and fueled bearish concern about continued share pressure. Bulls argue the financing supports Oklos long-term advanced-nuclear and AI data-center opportunity, while also watching for regulatory, power-contract, or other project catalysts.

Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.

Nuvation Bio Inc - Ordinary Shares - Class A

An FDA-approved supplemental label update for Ibtrozi (taletrectinib) added long-term Phase 2 durability data in first-line ROS1-positive lung cancer, reportedly arriving ahead of schedule. Traders largely view the update as strengthening Ibtrozis commercial and first-line positioning, though some debate the muted price reaction and competitive pressure from GSKs ROS1 program.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

A sharp, persistent selloff and underperformance versus the broader market have focused attention on Netflixs slowing growth, competition, and upcoming earnings, with traders debating whether the weakness reflects fundamental deterioration or technical and market-driven selling. Bears expect further downside, while bulls point to buybacks, advertising, live sports, and an oversold chart as potential supports.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Novo’s Obesity Drug Patients Granted Compensation In Denmark Over Rare Eye Disease Linked To Wegovy, Ozempic

Equity

The four claimants will receive a combined 800,000 kroner, though that figure may rise, Danish Patient Compensation said on Friday.


Novartis Opens New Manufacturing Facility In California In Bid To Increase US Presence

Commercial manufacturing at the facility is expected to begin once approval is granted by the U.S. Food and Drug Administration, the company added.


GMO ETF Trust - GMO International Quality ETF

Neutral Sentiment

No more this year

One more

Two more

The Federal Reserve raised interest rates by a quarter point to a range of 3.75%-4.00% on Wednesday, its first hike since July 2023, but Fed Chair Kevin Warsh signaled the tightening cycle isn't over. How many more rate hikes do you expect by the end of 2026? Vote and explain your reasoning in the comments.

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it&#39;s not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Stocktwits

The Fed hiked rates 25bps yesterday, its first since 2023, but signaled it's not done - projections point to one or two more hikes this year. How many total hikes do you expect by year-end?

Current Price	$26.68
Prev Close	$26.54
Open	$26.79
Dividend Yield	N/A
50-Day Moving Average	$27.25
Beta	N/A
Avg. Volume	11,604.23
PE Ratio	N/A

52-Week High	$28.20
52-Week Low	$24.22
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

QLTI Fundamentals